Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of tDCS on Cannabis Craving in Patients With Schizophrenia and Cannabis Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study

NCT05784961 is registered in ClinicalTrials.gov with Centre hospitalier de Ville-Evrard, France as lead sponsor.

NCT NCT05784961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05784961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of tDCS on Cannabis Craving in Patients With Schizophrenia and Cannabis Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
Lead sponsor
Centre hospitalier de Ville-Evrard, France
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2024
Completion date
June 20, 2027
Enrollment
138 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder, schizophrenia